XBiotech (XBIT) Current Assets (2014 - 2026)
XBiotech (XBIT) posted quarterly Current Assets of $127.0 million for Q4 2025, down 27.28% year-over-year from $174.6 million in Q4 2024, and down 14.77% quarter-over-quarter from $149.0 million in Q3 2025.
XBiotech (XBIT) Current Assets (2014 - 2026) Analysis & Trends
XBiotech's Current Assets history runs 12 years deep, the most recent figure standing at $127.0 million for Q4 2025.
- In Q4 2025, Current Assets fell 27.28% year-over-year to $127.0 million; the TTM figure through Dec 2025 stood at $127.0 million (down 27.28% YoY), while the FY2025 annual figure was $127.0 million, down 27.28% from the prior year.
- Current Assets for Q4 2025 stood at $127.0 million, down from $149.0 million in the prior quarter.
- The five-year high for Current Assets was $327.9 million in Q1 2021, with the low at $127.0 million in Q4 2025.
- The 5-year median for Current Assets is $207.0 million (2023), against an average of $212.4 million.
- The sharpest annual moves came in 2021 and 2025: Current Assets increased 27.14% in 2021, then dropped 27.28% in 2025.
- XBiotech's Current Assets stood at $246.9 million in 2021, then slipped by 10.95% to $219.8 million in 2022, then slipped by 8.24% to $201.7 million in 2023, then fell by 13.46% to $174.6 million in 2024, then slipped by 27.28% to $127.0 million in 2025.
- Business Quant data shows XBIT's Current Assets at $127.0 million in Q4 2025, $149.0 million in Q3 2025, and $154.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | 111.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 111.16 Mn |
| Dec 31, 2025 | 126.95 Mn |
| Sep 30, 2025 | 148.95 Mn |
| Jun 30, 2025 | 154.89 Mn |
| Mar 31, 2025 | 157.69 Mn |
| Dec 31, 2024 | 174.57 Mn |
| Sep 30, 2024 | 185.03 Mn |
| Jun 30, 2024 | 190.64 Mn |
| Mar 31, 2024 | 203.06 Mn |
| Dec 31, 2023 | 201.72 Mn |
| Sep 30, 2023 | 204.40 Mn |
| Jun 30, 2023 | 209.51 Mn |
| Mar 31, 2023 | 216.28 Mn |
| Dec 31, 2022 | 219.84 Mn |
| Sep 30, 2022 | 223.43 Mn |
| Jun 30, 2022 | 238.76 Mn |
| Mar 31, 2022 | 242.98 Mn |
| Dec 31, 2021 | 246.87 Mn |
| Sep 30, 2021 | 250.24 Mn |
| Jun 30, 2021 | 324.86 Mn |